Determination of Enantiomeric Purity of GSK962040 Based on Liquid Chromatography Using Chiral Stationary Phase Combined with a Pre-column Derivatization Procedure

[1]  N. Nguyen,et al.  The effect of camicinal (GSK962040), a motilin agonist, on gastric emptying and glucose absorption in feed-intolerant critically ill patients: a randomized, blinded, placebo-controlled, clinical trial , 2016, Critical Care.

[2]  G. Sanger,et al.  The pharmacodynamics, safety and pharmacokinetics of single doses of the motilin agonist, camicinal, in type 1 diabetes mellitus with slow gastric emptying , 2016, British journal of pharmacology.

[3]  Xin Wang,et al.  Determination of Repertaxin Enantiomeric Purity by HPLC on Chiral Stationary Phase , 2015, Chromatographia.

[4]  R. Hobson,et al.  The effects of camicinal, a novel motilin agonist, on gastro‐esophageal function in healthy humans—a randomized placebo controlled trial , 2015, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[5]  Yongmei Xie,et al.  Determination of the Enantiomeric Purity of Trelagliptin by Pre-Column Derivatization and Liquid Chromatography on a Chiral Stationary Phase , 2015, Chromatographia.

[6]  Yinglan Zhao,et al.  HPLC Determination of Enantiomeric Purity of PF-04136309 Based on a Chiral Stationary Phase , 2015, Chromatographia.

[7]  B. Kuo,et al.  The investigational drug camicinal for the treatment of gastroparesis , 2015, Expert opinion on investigational drugs.

[8]  G. Sanger,et al.  Drugs acting at 5‐HT4, D2, motilin, and ghrelin receptors differ markedly in how they affect neuromuscular functions in human isolated stomach , 2014, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[9]  G. Sanger,et al.  Ghrelin and motilin receptor agonists: time to introduce bias into drug design , 2014, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[10]  G. Sanger,et al.  Motilin: towards a new understanding of the gastrointestinal neuropharmacology and therapeutic use of motilin receptor agonists , 2013, British journal of pharmacology.

[11]  G. Sanger,et al.  Regional‐ and agonist‐dependent facilitation of human neurogastrointestinal functions by motilin receptor agonists , 2012, British journal of pharmacology.

[12]  J. Tack,et al.  Emerging drugs for functional dyspepsia , 2011, Expert opinion on emerging drugs.

[13]  H. Nakajima,et al.  Mechanism of interdigestive migrating motor complex in conscious dogs , 2010, Journal of Gastroenterology.

[14]  Erik Näslund,et al.  GSK962040: a small molecule, selective motilin receptor agonist, effective as a stimulant of human and rabbit gastrointestinal motility , 2009 .

[15]  A. Muir,et al.  Discovery of N-(3-fluorophenyl)-1-[(4-([(3S)-3-methyl-1-piperazinyl]methyl)phenyl)acetyl]-4-piperidinamine (GSK962040), the first small molecule motilin receptor agonist clinical candidate. , 2009, Journal of medicinal chemistry.

[16]  L. Otterbein,et al.  Development of potent, orally active 1-substituted-3,4-dihydro-2-quinolone glycogen phosphorylase inhibitors. , 2007, Bioorganic & medicinal chemistry letters.

[17]  R. Nageswara Rao,et al.  An improved and validated LC method for resolution of bicalutamide enantiomers using amylose tris-(3,5-dimethylphenylcarbamate) as a chiral stationary phase. , 2006, Journal of pharmaceutical and biomedical analysis.

[18]  R. Cuomo,et al.  Influence of Motilin on Gastric Fundus Tone and on Meal-Induced Satiety in Man: Role of Cholinergic Pathways , 2006, The American Journal of Gastroenterology.

[19]  Y. Liu,et al.  Chiral separation of enantiomers of amino acid derivatives by high-performance liquid chromatography on a norvancomycin-bonded chiral stationary phase. , 2004, Talanta.

[20]  S. Olesik,et al.  Chiral separation by simultaneous use of vancomycin as stationary phase chiral selector and chiral mobile phase additive. , 2000, Journal of chromatography. B, Biomedical sciences and applications.

[21]  G. Hollingworth,et al.  Developments and Advances in Gastrointestinal Prokinetic Agents , 2011 .